A drug that stops cancer treatments damaging ovaries could preserve patients’
fertility. Researchers at the Memorial Sloan-Kettering Cancer Center and
Massachusetts General Hospital injected a compound called
sphingosine-1-phosphate into the ovaries of mice. This prevented a lipid in the
membrane of an egg cell being converted into another lipid called ceramide and
starting a chain reaction that ends in cell suicide (Nature Medicine,
vol 6, p 1109). “If they have stopped [cell death] and produced normal embryos
from the ovaries, this is fantastic,” says Geraldine Hartshorne of the University of Warwick.
To continue reading, today with our introductory offers
Advertisement
More from Âé¶¹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Âé¶¹´«Ã½ articles
1
Are Neanderthals descendants of modern humans?
2
Is a super El Niño imminent, and what could the impacts be?
3
Hospital-acquired pneumonia reduced by daily toothbrushing
4
Neanderthal infants were enormous compared with modern humans
5
We might finally know how to use quantum computers to boost AI
6
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
7
The biggest threat to Chernobyl is no longer radiation
8
Collapse of key ocean current may release billions of tonnes of carbon
9
Why is it so hard to change your mind?
10
The rise, the fall and the rebound of cyclic cosmology



